BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2020
View Archived Issues
'Undruggable' phosphatase can be targeted for dystrophies
Read More
New phase II study evaluates inhaled ensifentrine in hospitalized patients with COVID-19
Read More
Chewing the fat keeps stem cells quiet
Read More
FDA accepts IND for ABP-450 as a treatment for cervical dystonia
Read More
ESsCOVID study of trimodulin in patients with COVID-19 receives approval in Spain
Read More
University of California patents lentiviral vectors for hemoglobinopathies
Read More
Spanish researchers identify new SFRP1-targeting antibodies for Alzheimer's disease
Read More
Astellas Pharma presents new CXC3-CL1-encoding AAV vectors for retinal degeneration
Read More
Beijing Sanyou Liheze Biological Technology discovers potential stem cell therapy for COPD
Read More
New OX40-targeting antibodies presented by Zhengzhou Airport Baiqiao Biotechnology
Read More
Two gut bacteria combine to exacerbate MS symptoms
Read More
Akebia reports topline data from its PRO2TECT global phase III program of vadadustat
Read More
Researchers identify new cardiac syndrome tied to deletion of chromosome locus 4q25
Read More
Enrollment opens in phase I study of LY-3410738 in advanced solid tumors with IDH1 mutations
Read More
Relay begins first-in-human evaluation of FGFR2 inhibitor RLY-4008
Read More
Increased expression of MUDENG linked to accelerated liver fibrosis in mice
Read More
City of Hope tests leflunomide in cancer patients with COVID-19
Read More
Savara ends exploratory study of Molgradex for nontuberculous mycobacterial lung infection in CF
Read More
BIO89-100 enters phase II trial for severe hypertriglyceridemia
Read More
Auris advances phase II trial of intranasal betahistine for vertigo
Read More
Clear Creek Bio starts phase I study of brequinar for treatment of COVID-19
Read More
Orca Bio and Lyell partner on next-generation T-cell therapies
Read More